{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T12:45:09Z","timestamp":1790858709852,"version":"4.1.0"},"reference-count":35,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,3,19]],"date-time":"2018-03-19T00:00:00Z","timestamp":1521417600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["91642205, 81471535, 81701176"],"award-info":[{"award-number":["91642205, 81471535, 81701176"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000890","name":"National Multiple Sclerosis Society","doi-asserted-by":"publisher","award":["RG-1507-05318"],"award-info":[{"award-number":["RG-1507-05318"]}],"id":[{"id":"10.13039\/100000890","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2018.00523","type":"journal-article","created":{"date-parts":[[2018,3,19]],"date-time":"2018-03-19T11:09:36Z","timestamp":1521457776000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":16,"title":["Astrocytic Interleukin-15 Reduces Pathology of Neuromyelitis Optica in Mice"],"prefix":"10.3389","volume":"9","author":[{"given":"Zhiguo","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinrui","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Honglei","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cun-Gen","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fu-Dong","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minshu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,3,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/B978-0-444-63432-0.00021-9","article-title":"Autoimmune AQP4 channelopathies and neuromyelitis optica spectrum disorders","volume":"133","author":"Hinson","year":"2016","journal-title":"Handb Clin Neurol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/S1474-4422(07)70216-8","article-title":"The spectrum of neuromyelitis optica","volume":"6","author":"Wingerchuk","year":"2007","journal-title":"Lancet Neurol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1093\/brain\/awf151","article-title":"A role for humoral mechanisms in the pathogenesis of Devic\u2019s neuromyelitis optica","volume":"125","author":"Lucchinetti","year":"2002","journal-title":"Brain"},{"key":"B4","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/nrneurol.2010.72","article-title":"AQP4 antibodies in neuromyelitis optica: diagnostic and pathogenetic relevance","volume":"6","author":"Jarius","year":"2010","journal-title":"Nat Rev Neurol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1084\/jem.20050304","article-title":"IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel","volume":"15","author":"Lennon","year":"2005","journal-title":"J Exp Med"},{"key":"B6","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.jneuroim.2009.07.014","article-title":"Cytotoxic effect of neuromyelitis optica antibody (NMO-IgG) to astrocytes: an in vitro study","volume":"30","author":"Sabater","year":"2009","journal-title":"J Neuroimmunol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1016\/j.it.2016.06.006","article-title":"Astrocytes: key regulators of neuroinflammation","volume":"37","author":"Colombo","year":"2016","journal-title":"Trends Immunol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.jaut.2014.05.004","article-title":"NMO spectrum of disorders: a paradigm for astrocyte-targeting autoimmunity and its implications for MS and other CNS inflammatory diseases","volume":"54","author":"Vaknin-Dembinsky","year":"2014","journal-title":"J Autoimmun"},{"key":"B9","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1111\/j.1365-2249.2012.04661.x","article-title":"Characterization of the interaction between astrocytes and encephalitogenic lymphocytes during the development of experimental autoimmune encephalitomyelitis (EAE) in mice","volume":"170","author":"Yang","year":"2012","journal-title":"Clin Exp Immunol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1038\/nm0297-189","article-title":"Interleukin-15 mediates T cell-dependent regulation of tumor necrosis factor-alpha production in rheumatoid arthritis","volume":"3","author":"McInnes","year":"1997","journal-title":"Nat Med"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1016\/S0016-5085(98)70430-5","article-title":"Interleukin 15 activity in the rectal mucosa of inflammatory bowel disease","volume":"114","author":"Sakai","year":"1998","journal-title":"Gastroenterology"},{"key":"B12","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1002\/glia.20628","article-title":"Interleukin 15 expression in the CNS: blockade of its activity prevents glial activation after an inflammatory injury","volume":"56","author":"Gomez-Nicola","year":"2008","journal-title":"Glia"},{"key":"B13","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1186\/s12974-017-0921-7","article-title":"A translocator protein 18 kDa agonist protects against cerebral ischemia\/reperfusion injury","volume":"28","author":"Li","year":"2017","journal-title":"J Neuroinflammation"},{"key":"B14","doi-asserted-by":"publisher","first-page":"2383","DOI":"10.1177\/0271678X16666551","article-title":"Colony stimulating factor 1 receptor inhibition eliminates microglia and attenuates brain injury after intracerebral hemorrhage","volume":"37","author":"Li","year":"2017","journal-title":"J Cereb Blood Flow Metab"},{"key":"B15","doi-asserted-by":"publisher","first-page":"E396","DOI":"10.1073\/pnas.1612930114","article-title":"Astrocyte-derived interleukin-15 exacerbates ischemic brain injury via propagation of cellular immunity","volume":"17","author":"Li","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B16","doi-asserted-by":"publisher","first-page":"5693","DOI":"10.4049\/jimmunol.1002188","article-title":"Contribution of astrocyte-derived IL-15 to CD8 T cell effector functions in multiple sclerosis","volume":"15","author":"Saikali","year":"2010","journal-title":"J Immunol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.expneurol.2009.12.034","article-title":"Aggravated experimental autoimmune encephalomyelitis in IL-15 knockout mice","volume":"222","author":"Gomez-Nicola","year":"2010","journal-title":"Exp Neurol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.jneuroim.2010.04.001","article-title":"Cerebral interleukin-15 shows upregulation and beneficial effects in experimental autoimmune encephalomyelitis","volume":"223","author":"Wu","year":"2010","journal-title":"J Neuroimmunol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1002\/ana.21802","article-title":"Intrathecal pathogenic anti-aquaporin-4 antibodies in early neuromyelitis optica","volume":"66","author":"Bennett","year":"2009","journal-title":"Ann Neurol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.immuni.2017.02.015","article-title":"Brain ischemia suppresses immunity in the periphery and brain via different neurogenic innervations","volume":"21","author":"Liu","year":"2017","journal-title":"Immunity"},{"key":"B21","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.jneuroim.2013.09.008","article-title":"Visualization of inflammation and demyelination in 2D2 transgenic mice with rodent MRI","volume":"15","author":"Bell","year":"2013","journal-title":"J Neuroimmunol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1161\/STROKEAHA.117.018904","article-title":"Selective NLRP3 (pyrin domain-containing protein 3) inflammasome inhibitor reduces brain injury after intracerebral hemorrhage","volume":"49","author":"Ren","year":"2018","journal-title":"Stroke"},{"key":"B23","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.neuroscience.2013.10.049","article-title":"Genetic deficiency of beta2-containing nicotinic receptors attenuates brain injury in ischemic stroke","volume":"3","author":"Liu","year":"2014","journal-title":"Neuroscience"},{"key":"B24","doi-asserted-by":"publisher","first-page":"860","DOI":"10.4049\/jimmunol.1103451","article-title":"A role for the NF-kappaB pathway in cell protection from complement-dependent cytotoxicity","volume":"15","author":"Gancz","year":"2012","journal-title":"J Immunol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.jns.2013.05.035","article-title":"NMO sera down-regulate AQP4 in human astrocyte and induce cytotoxicity independent of complement","volume":"15","author":"Haruki","year":"2013","journal-title":"J Neurol Sci"},{"key":"B26","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1002\/glia.22635","article-title":"Neuromyelitis optica IgG stimulates an immunological response in rat astrocyte cultures","volume":"62","author":"Howe","year":"2014","journal-title":"Glia"},{"key":"B27","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1146\/annurev.immunol.24.021605.090727","article-title":"Diverse functions of IL-2, IL-15, and IL-7 in lymphoid homeostasis","volume":"24","author":"Ma","year":"2006","journal-title":"Annu Rev Immunol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1038\/nri1901","article-title":"The biology of interleukin-2 and interleukin-15: implications for cancer therapy and vaccine design","volume":"6","author":"Waldmann","year":"2006","journal-title":"Nat Rev Immunol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1111\/imm.12212","article-title":"Rituximab-induced interleukin-15 reduction associated with clinical improvement in rheumatoid arthritis","volume":"142","author":"Diaz-Torne","year":"2014","journal-title":"Immunology"},{"key":"B30","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.brainres.2009.09.009","article-title":"Effects of interleukin-15 on neuronal differentiation of neural stem cells","volume":"22","author":"Huang","year":"2009","journal-title":"Brain Res"},{"key":"B31","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1007\/s00401-013-1128-3","article-title":"C1q-targeted monoclonal antibody prevents complement-dependent cytotoxicity and neuropathology in in vitro and mouse models of neuromyelitis optica","volume":"125","author":"Phuan","year":"2013","journal-title":"Acta Neuropathol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1002\/ana.22657","article-title":"Anti-aquaporin-4 monoclonal antibody blocker therapy for neuromyelitis optica","volume":"71","author":"Tradtrantip","year":"2012","journal-title":"Ann Neurol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1111\/bpa.12098","article-title":"Experimental models of neuromyelitis optica","volume":"24","author":"Bradl","year":"2014","journal-title":"Brain Pathol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.msard.2012.06.003","article-title":"Review of Animal models of neuromyelitis optica","volume":"1","author":"Jones","year":"2012","journal-title":"Mult Scler Relat Disord"},{"key":"B35","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1007\/s12264-015-1552-6","article-title":"Experimental models of neuromyelitis optica: current status, challenges and future directions","volume":"31","author":"Li","year":"2015","journal-title":"Neurosci Bull"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2018.00523\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,3,19]],"date-time":"2018-03-19T11:09:41Z","timestamp":1521457781000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2018.00523\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,19]]},"references-count":35,"alternative-id":["10.3389\/fimmu.2018.00523"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2018.00523","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,19]]},"article-number":"523"}}